Juan Frias
Directeur Technique/Scientifique/R&D chez BIOMEA FUSION, INC.
Profil
Juan Pablo Frias is currently the Director at T1D Exchange and the Chief Medical Officer at Biomea Fusion, Inc. He previously served as the Chief Executive Officer at the National Research Institute from 2013 to 2020.
He also held the position of President & Chief Executive Officer at NRI Clinical Research LLC.
Additionally, he worked as the Medical Director at Velocity Clinical Research, Inc. and as the Chief Medical Officer at Johnson & Johnson from 2007 to 2010.
Postes actifs de Juan Frias
Sociétés | Poste | Début |
---|---|---|
BIOMEA FUSION, INC. | Directeur Technique/Scientifique/R&D | 31/08/2023 |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Directeur/Membre du Conseil | - |
Anciens postes connus de Juan Frias
Sociétés | Poste | Fin |
---|---|---|
National Research Institute
National Research Institute BiotechnologyHealth Technology National Research Institute provides therapies for health care. The firm focuses on therapeutic areas that affect minorities such as obesity, diabetes, hypertension, vaccines, dyslipidemias, hepatitis C, and osteoporosis, among others. It offers access to therapies through clinical research. The company was founded in 1981 and is headquartered in Los Angeles, CA. | Directeur Général | 01/10/2020 |
JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | 01/07/2010 |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Velocity Clinical Research, Inc. engages in the provision of clinical investigation and clinical trial data. The firm also offers healthcare and research and development services. The company was founded by Bruce Tomason in 2017 and is headquartered in Durham, NC. | Directeur Technique/Scientifique/R&D | - |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology NRI Clinical Research LLC provides innovative investigational therapies to patients through clinical studies. It focuses on the therapeutic areas that affect minorities such as obesity, diabetes, hypertension, vaccines, dyslipidemias, hepatitis C, and osteoporosis. The company was founded on July 19, 2011 and is headquartered in Los Angeles, CA. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
BIOMEA FUSION, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
National Research Institute
National Research Institute BiotechnologyHealth Technology National Research Institute provides therapies for health care. The firm focuses on therapeutic areas that affect minorities such as obesity, diabetes, hypertension, vaccines, dyslipidemias, hepatitis C, and osteoporosis, among others. It offers access to therapies through clinical research. The company was founded in 1981 and is headquartered in Los Angeles, CA. | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Health Technology |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Velocity Clinical Research, Inc. engages in the provision of clinical investigation and clinical trial data. The firm also offers healthcare and research and development services. The company was founded by Bruce Tomason in 2017 and is headquartered in Durham, NC. | Technology Services |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology NRI Clinical Research LLC provides innovative investigational therapies to patients through clinical studies. It focuses on the therapeutic areas that affect minorities such as obesity, diabetes, hypertension, vaccines, dyslipidemias, hepatitis C, and osteoporosis. The company was founded on July 19, 2011 and is headquartered in Los Angeles, CA. | Health Technology |